#Rituximab is an anti-CD20 monoclonal antibody medication used to treat some oncology diseases (B-cell non-Hodgkin's lymphoma, B-cell chronic lymphocytic leukemia etc) and autoimmune disorders. It targets and helps the immune system destroy B-cells, which are a type of white blood cells. Rituximab is approved for several non-cancer conditions, primarily severe autoimmune diseases, where B-cells play a key role in causing inflammation and tissue damage. In these disorders, ri

Cancer and it's treatment can weaken the body's immune system by affection the blood cells that protect against germs. Following SAFE...